PHAR presented research spanning the spanning the areas of rare disease, oncology, neurology, and infectious disease. Three of their posters examined and reported on the use of genomic screening/testing to improve outcomes in multiple types of advanced cancers. PHAR’s researchers also contributed to three posters on the benefits of a novel antiviral treatment for COVID-19, on the development of algorithms to identify non-relapsing secondary progressive multiple sclerosis in electronic health data, and on healthcare resource utilization and costs related to the management of tuberous sclerosis complex, a rare genetic disorder.
All of these posters can be found on the PHAR publications page, and accompanying abstracts will be published in the June 2023 ISPOR supplement of Value in Health.